EFTR

eFFECTOR Therapeutics, Inc. Common Stock

Delisted

EFTR was delisted on the 2nd of July, 2024.

58 hedge funds and large institutions have $116M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+15
Holders Change %
+34.88%
% of All Funds
1.01%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
20
Increased
15
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
WMSA
51
Weiss Multi-Strategy Advisers
New York
$148K +$148K +600 New
CAPTRUST Financial Advisors
52
CAPTRUST Financial Advisors
North Carolina
$138K
CCM
53
Context Capital Management
California
$95K +$95K +386 New
UBS Group
54
UBS Group
Switzerland
$20K +$20K +80 New
MI
55
MMCAP International
Cayman Islands
$6.19K +$1.24K +5,018 +25%
Morgan Stanley
56
Morgan Stanley
New York
$6K +$1K +4 +20%
PA
57
Parallel Advisors
California
$2K +$2K +10 New
Walleye Capital
58
Walleye Capital
New York
$297 +$297 +1,200 New
Blackstone Inc
59
Blackstone Inc
New York
-$2.93M -12,000 Closed
SSA
60
Schonfeld Strategic Advisors
New York
-$1.24M -5,131 Closed
HighTower Advisors
61
HighTower Advisors
Illinois
-$240K -1,001 Closed
FTUS
62
Flow Traders U.S.
New York
-$225K -934 Closed
RA
63
Ramius Advisors
New York
-$168K -688 Closed